0001022079-17-000174.txt : 20170907
0001022079-17-000174.hdr.sgml : 20170907
20170907164046
ACCESSION NUMBER: 0001022079-17-000174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170905
FILED AS OF DATE: 20170907
DATE AS OF CHANGE: 20170907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUSCKOWSKI STEPHEN H
CENTRAL INDEX KEY: 0001142624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 171074249
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_150481683383336.xml
FORM 4
X0306
4
2017-09-05
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001142624
RUSCKOWSKI STEPHEN H
500 PLAZA DRIVE
SECAUCUS
NJ
07094
1
1
0
0
Chairman, President and CEO
Common Stock
2017-09-05
4
M
0
2525
58.175
A
168413
D
Common Stock
2017-09-05
4
S
0
2525
108.027
D
166116
D
Stock Options (Right to Buy)
58.175
2017-09-05
4
M
0
2525
58.175
D
2022-05-01
Common Stock
2525.0
166075
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.
This transaction was executed in multiple trades at prices ranging from $108.00 to $108.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
The options vested in three annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski
2017-09-07